Medical specialists from France tagged as investigators in clinical trials studying Epilepsies, Partial

Total 24 results

Anne DE SAINT MARTIN
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Principal Investigator)
Conditions:
Baptiste Morel
Seen in:
- Tours, Hôpital Clocheville
Trials:
- NCT05100771 (Principal Investigator)
Conditions:
- Focal Epilepsy
BENOILID Aurélien, MD
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT02885207 (Principal Investigator)
Conditions:
- Epilepsy
Bertrand BRUNEAU
Seen in:
- Rennes, CHU Rennes
Trials:
- NCT05100771 (Principal Investigator)
Conditions:
- Focal Epilepsy
Calina TODOSI
Seen in:
- Nancy, Hopital D'Enfants Pediatrie Medicale Ambulatoire
Trials:
- NCT03865771 (Principal Investigator)
Conditions:
Chantal DURAND
Seen in:
- Grenoble, CHU Grenoble
Trials:
- NCT05100771 (Principal Investigator)
Conditions:
- Focal Epilepsy
Charles BEHR
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT03321240 (Sub-Investigator)
Conditions:
Clémentine LAMBERT
Seen in:
- Nancy, Hopital D'Enfants Pediatrie Medicale Ambulatoire
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Clotilde BOULAY
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Edouard HIRSCH
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT03321240 (Principal Investigator)
- NCT03865771 (Sub-Investigator)
Conditions:
Georg Dorfmüller, MD
Seen in:
- Paris, Fondation Ophtalmologique Adolphe de Rothschld
Trials:
- NCT02890641 (Principal Investigator)
Conditions:
Hélène VINCENT
Seen in:
- Nancy, Hopital D'Enfants Pediatrie Medicale Ambulatoire
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Louis Marie LEIBER
Seen in:
- Angers, Chu Angers
Trials:
- NCT05100771 (Principal Investigator)
Conditions:
- Focal Epilepsy
Marie Aude SPITZ
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Marie-Thérèse ABI WARDE
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Mathieu KUCHENBUCH
Seen in:
- Nancy, Hopital D'Enfants Pediatrie Medicale Ambulatoire
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Nicolas LEBOUCQ
Seen in:
- Montpellier, CHU Montpellier
Trials:
- NCT05100771 (Principal Investigator)
Conditions:
- Focal Epilepsy
Paola VALENTI HIRSCH
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Pauline DENIAU
Seen in:
- Nancy, Hopital D'Enfants Pediatrie Medicale Ambulatoire
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Rima NABBOUT, Pr
Seen in:
- Paris, Centre de Référence Epilepsies Rares / Centre Investigation Clinique (CIC) - Hôpital Necker-Enfants Malades
Trials:
- NCT05419180 (Principal Investigator)
Conditions:
- Pharmacoresistant Focal Epilepsies
Sarah BAER
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
Trials:
- NCT03865771 (Sub-Investigator)
Conditions:
Stéphanie Baulac, PhD
Seen in:
- Paris, Fondation Ophtalmologique Adolphe de Rothschld
Trials:
- NCT02890641 (Sub-Investigator)
Conditions:
Vincent LAUGEL
Seen in:
- Strasbourg, Hopital de Hautepierre-Service de Pediatrie/Neurologie
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT03865771 (Sub-Investigator)
- NCT04406480 (Sub-Investigator)
Conditions:

Clinical Trials on Epilepsies, Partial

UCB Pharma

Completed

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (SELF)

Partial Epilepsies

France
UCB Pharma

Completed

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States, Poland, United Kingdom, Switzerland, Hungary, Germany, Sweden, Lithuania
UCB BIOSCIENCES, Inc.

Completed

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
UCB BIOSCIENCES, Inc.

Completed

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States
UCB Pharma

Completed

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Partial Epilepsies

United States, Austria, Bulgaria, Czechia, Denmark, Finland, France, Greece, Italy, Mexico, Romania, Russian Federation, Spain, Switzerland, Turkey
Institut National de la Santé Et de la Recherche...

Unknown

Structural and Functional Connectivity in Partial Epilepsies Studied With MRI and MEG

Epilepsies

France
UCB BIOSCIENCES, Inc.

Completed

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
Vertex Pharmaceuticals Incorporated

Terminated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Epilepsy

United States, Germany
Bial - Portela C S.A.

Completed

Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive

Partial Epilepsy

Portugal
GlaxoSmithKline

Completed

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

Epilepsy

Medical specialists from France tagged as investigators in clinical trials studying Epilepsies, Partial

Clinical Trials on Epilepsies, Partial

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations